Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.4 USD | +3.51% | +16.54% | +13.24% |
Financials (USD)
Sales 2024 * | 27.66M | Sales 2025 * | 18.47M | Capitalization | 85.76M |
---|---|---|---|---|---|
Net income 2024 * | -24M | Net income 2025 * | -65M | EV / Sales 2024 * | -0.09 x |
Net cash position 2024 * | 88.17M | Net cash position 2025 * | 64.24M | EV / Sales 2025 * | 1.17 x |
P/E ratio 2024 * |
-3.57
x | P/E ratio 2025 * |
-2.23
x | Employees | 109 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 0% |
Latest transcript on Precision BioSciences, Inc.
1 day | +3.51% | ||
1 week | +16.54% | ||
Current month | +19.12% | ||
1 month | +15.67% | ||
3 months | +4.64% | ||
6 months | -5.33% | ||
Current year | +13.24% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Amoroso
CEO | Chief Executive Officer | 46 | 21-10-14 |
Jeff Smith
FOU | Founder | - | 06-01-25 |
John Kelly
DFI | Director of Finance/CFO | 57 | 20-10-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin Buehler
CHM | Chairman | 66 | 19-11-07 |
Geno Germano
BRD | Director/Board Member | 63 | 20-03-09 |
Samuel Wadsworth
BRD | Director/Board Member | 75 | 21-11-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.16% | 2 M€ | -25.75% | ||
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 12.4 | +3.51% | 38,963 |
24-05-16 | 11.98 | -0.91% | 23,572 |
24-05-15 | 12.09 | +4.04% | 87,860 |
24-05-14 | 11.62 | +1.04% | 25,807 |
24-05-13 | 11.5 | +8.08% | 105,794 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
- Stock Market
- Equities
- DTIL Stock